🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Arlene O. Siefker‐Radtke

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-6328-9599

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies”.

Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies

Cancer(2020)10.1002/cncr.33328

N/A

3.1DataRank · unranked

113 citations

Matthew T. Campbell, Wanling Xie, Subrina Farah, Mehmet Asım Bilen, Andrew Schmidt +11 more

Molecular profile of micropapillary urothelial carcinoma of the urinary bladder: An analysis of 99 cases by next-generation sequencing

Human Pathology(2025)10.1016/j.humpath.2025.105812

N/A

0.241DataRank · unranked

4 citations

Lan Zheng, Jianping Zhao, Yishan Wang, Hui Chen, Sinchita Roy‐Chowdhuri +9 more

Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.07.004

N/A

0DataRank · unranked

2 citations

Andrew W. Hahn, Pavlos Msaouel, Funda Meric‐Bernstam, Nathaniel R. Wilson, Aung Naing +18 more

Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma

American Journal of Clinical Pathology(2022)10.1093/ajcp/aqac039

N/A

0DataRank · unranked

10 citations

Hui Chen, Sinchita Roy‐Chowdhuri, Keyur P. Patel, Rajyalakshmi Luthra, Mark J. Routbort +6 more

1752P Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011

Annals of Oncology(2022)10.1016/j.annonc.2022.07.1830

N/A

0DataRank · unranked

1 citations

T. Csoszi, N. Matsubara, Su‐Jin Shin, S.H. Park, Vagif Atduev +15 more

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03383-w

N/A

0DataRank · unranked

4 citations

Amy K. Erbe, Jennifer Birstler, KyungMann Kim, Ute Hoch, Sue Currie +8 more

Plasmacytoid urothelial carcinoma of the urinary bladder–A clinicopathological and molecular analysis of 52 cases

Human Pathology(2024)10.1016/j.humpath.2024.04.012

N/A

0DataRank · unranked

8 citations

Hui Chen, Jianping Zhao, Sinchita Roy‐Chowdhuri, Ashish M. Kamat, Omar Alhalabi +6 more

Plain language summary of the THOR Cohort 1 study comparing treatment with erdafitinib or chemotherapy in advanced or metastatic urothelial cancer

Future Oncology(2025)10.1080/14796694.2025.2511589

N/A

0DataRank · unranked

0 citations

Spyros Triantos, Kris Deprince, Arlene O. Siefker‐Radtke, Yohann Loriot

Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0751

N/A

0DataRank · unranked

11 citations

Andrew W. Hahn, Pavlos Msaouel, Alexander Andreev-Drakhlin, Funda Meric‐Bernstam, Aung Naing +17 more